Abstract:Myocardial viability was assessed by Tc-99m-methoxyisobutylisonitrile (MIBI) SPELT and F-18-FDG PET to evaluate the prognosis and treatment strategy of patients with myocardial infarction (MI) and left ventricular (LV) dysfunction. Methods: One hundred twenty-three consecutive patients with previous MI and LV dysfunction (LV ejection fraction [EF], 35%+/-6% [mean +/- SD]) who underwent Tc-99m-MIBI SPELT and FDG PET were followed-up for 26 +/- 10 mo (mean +/- SD). Distributions of the 2 radiotracers in myocardial segments were classified into 2 patterns: myocardial perfusion-metabolism mismatch (MM) and match (M). LV EF and LV end-diastolic diameter (EDD) were measured by echocardiography at baseline, 3 mo (Pos1), and 6 mo (Pos2) after revascularization. Cardiac death, acute MI, unstable angina, and late revascularization (>3 mo) experienced by the patients during follow-up were defined as cardiac events. Results: Sixty-seven patients underwent revascularization and 56 patients were treated medically. Of the 72 patients with greater than or equal to2 MM segments, 42 underwent revascularization (group A1) and 30 were treated medically (group A2). Of the 51 patients with <2 MM segments, 25 underwent revascularization (group B1) and 26 were treated medically (group B2). The 4 groups had similar baseline characteristics and rest LV EF. After revascularization, EF (mean SD) increased in group A1 from 36%5% to 44%+/-8% (P<0.0001) in Post and to 51%9% (P<0.0001) in Post. EDD (meanSD) decreased from 62 +/-8 mm to 56 +/-5 mm (P<0.001) in Post and to 555 mm (P<0.001) in Post. However, EF and EDD were unchanged in group B1 (P>0.05). During the follow-up, 22 patients (17.9%) suffered from cardiac events, including 11 cardiac deaths, 4 acute MI, 6 late coronary artery bypass grafting, and 1 unstable angina pectoris. The cardiac event rate in group A2 (50%) was significantly higher than that of groups A1 (2.4%; chi (2) = 23.08; P<0.0001), B1 (12%; (2) = 8.94; P = 0.003), and B2 (11.5%; chi (2) = 9.45; P = 0.002). Conclusion: Assessment of myocardial viability using hybrid Tc-99m-MIBI SPELT and FDG PET can predict the clinical outcome and is helpful to decision making in the treatment strategy of patients with MI and LV dysfunction. Revascularization can improve the LV function and clinical outcome of patients with >2 viable myocardial segments.

Association of Myocardial Viability on Nitrate-Augmented Technetium-99M Hexakis-2-methoxylisobutyl Isonitrile Myocardial Tomography and Intermediate-Term Outcome in Patients with Prior Myocardial Infarction and Left Ventricular Dysfunction.

Clinical Outcome of Patients with Previous Myocardial Infarction and Left Ventricular Dysfunction Assessed with Myocardial (99M)tc-Mibi SPECT and (18)F-FDG PET.

Effect of Breviscapine on Recovery of Viable Myocardium and Left Ventricular Remodeling in Chronic Total Occlusion Patients after Revascularization: Rationale and Design for a Randomized Controlled Trial

Long-term Survival of Patients with Viable and Nonviable Aneurysms Assessed by 99Mtc-Mibi SPECT and 18F-FDG PET: a Comparative Study of Medical and Surgical Treatment.

The relationship of myocardial viability of three coronary arterys dominated areas and the long-term adverse cardiovascular events following the coronary artery bypass graft

Long-term survival of patients with left ventricular aneurysm assessed by 99Tcm-MIBI SPECT and 18F-FDG PET

Impact of Viable Myocardium Assessed by 99Tcm-Mibi SPECT and 18F-FDG PET Imaging on Clinical Outcome of Patients with Left Ventricular Aneurysm Underwent Revascularization

The Relationship Between Local Myocardial Viability and Long Term Adverse Cardiovascular Events after Coronary Artery Bypass Graft

18F-FDG/99Tcm-MIBI SPECT myocardial imaging for the detection of myocardial viability in patients with acute myocardial infarction

Prognosis for Spect Test of Myocardial Viability of the Long-Term Adverse Cardiovascular Events Following the Coronary Artery Bypass Graft

Off-pump Coronary Artery Bypass Surgery Outcomes in Patients with Ischaemic Left Ventricular Systolic Dysfunction with or Without Detected Viable Myocardium.

Nitrate-augmented Myocardial Perfusion Imaging for Assessment of Myocardial Viability: Recent Advances

Assessment of Myocardial Viability in Ischemic Cardiomyopathy With Reduced Left Ventricular Function Undergoing Coronary Artery Bypass Grafting

The Influence of Myocardial Viability on Left Ventricular Remodeling and Cardiac Function in Patient with Acute Myocardial Infarction

Factors Related to the Myocardial Viability after Acute Myocardial Infarction

Determination of viable myocardium through delayed enhancement cardiac magnetic resonance imaging combined with 18F-FDG PET myocardial perfusion/metabolic imaging before CABG

~(99M)tc-Mibi Myocardial SPECT Imaging for Evaluation of Outcome in Patients after Coronary Angioplasty

Prognostic value of nitrate-augmented 99 Tcm-MIBI SPECT in patients with CHD and left ventricular dysfunction

Cardiac Death in Patients with Left Ventricular Aneurysm, Remodeling and Myocardial Viability by Gated 99m Tc-MIBI SPECT and Gated 18 F-FDG PET

Assessment of Myocardial Viability With 99m Tc-Sestamibi Tomography Before Coronary Bypass Graft Surgery

Predictive Value of Viable Myocardium of Papillary Muscle-Ventricular Wall Complex for Improvement in Moderate Ischemic Mitral Regurgitation